Imaging of the 5-HT2A system: age-, gender-, and Alzheimer's disease-related findings.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Neurobiology of Aging

• Publication date

  2003-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0197-4580(02)00137-9PMID 12714112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Greater loss of 5-HT(2A) receptors in midlife than in late life.

  2002cited by this paper
• The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.

  2001cited by this paper
• Variability in the 5-HT2A receptor gene is associated with seasonal pattern in major depression

  2001cited by this paper
• Association between 5-HT(2A) receptor polymorphism and psychotic symptoms in Alzheimer's disease.

  2001cited by this paper
• Decreased frontal serotonin 5-HT2a receptor binding index in deliberate self-harm patients

  2001cited by this paper
• Automated stereotactic standardization of brain SPECT receptor data using single-photon transmission images.

  2001cited by this paper
• The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors.

  2001cited by this paper
• Role of serotonin in memory impairment

  2000cited by this paper
• Deficit in sensory motor processing in depression and Alzheimer's disease: a study with EMG and event related potentials.

  2000cited by this paper
• Regulation of APP Synthesis and Secretion by Neuroimmunophilin Ligands and Cyclooxygenase Inhibitors

  2000cited by this paper
• Inflammation and Alzheimer's disease.

  2000cited by this paper
• Nonuniform transmission in brain SPECT using 201Tl, 153Gd, and 99mTc static line sources: anthropomorphic dosimetry studies and influence on brain quantification.

  2000cited by this paper
• PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.

  1999influential reference
• A review of central 5-HT receptors and their function.

  1999cited by this paper
• 5-HT system and cognition.

  1999cited by this paper
• Prostaglandin E2 Stimulates Amyloid Precursor Protein Gene Expression: Inhibition by Immunosuppressants

  1999cited by this paper
• The influence of prolactin response to d-fenfluramine on executive functioning in major depression.

  1999cited by this paper
• Serotonin-immune interactions in elderly volunteers and in patients with Alzheimer’s disease (DAT): Lower plasma tryptophan availability to the brain in the elderly and increased serum interleukin-6 in DAT

  1998cited by this paper
• Role of serotonin in the immune system and in neuroimmune interactions.

  1998cited by this paper
• Reduced binding of [18F]altanserin to serotonin type 2A receptors in aging: persistence of effect after partial volume correction.

  1998cited by this paper
• Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation.

  1998cited by this paper
• 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease.

  1998cited by this paper
• 123I-5-I-R91150, a new single-photon emission tomography ligand for 5-HT2A receptors: influence of age and gender in healthy subjects

  1998cited by this paper
• Initial evaluation of123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects

  1997cited by this paper
• Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects.

  1997cited by this paper
• [Usefulness of the 'Mini-Mental State Test'for the diagnosis of dementia; study of criterion validity in a Dutch rural population].

  1997cited by this paper
• Erratum: Initial evaluation of 123 I-5-I-R91150, a selective 5-HT(2A) ligand for single-photon emission tomography, in healthy human subjects (European Journal of Nuclear Medicine (1997) 24 (119-124))

  1997cited by this paper
• Serotonin receptors in cognitive behaviors.

  1997cited by this paper
• Evaluation of dementia.

  1996cited by this paper
• Sex difference in 5HT2 receptor in the living human brain.

  1996cited by this paper
• Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion (*)

  1996cited by this paper
• Modulation of cortical acetylcholine release by serotonin: the role of substance P interneurons

  1996cited by this paper
• Interrelationship of Age, Depression, and Central Serotonergic Function: Evidence From Fenfluramine Challenge Studies

  1996cited by this paper
• Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.

  1996cited by this paper
• Regulation of APP Processing Potential for the Therapeutical Reduction of Brain Amyloid Burden a

  1996cited by this paper
• Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions.

  1995cited by this paper
• [Differentiation between dementia and functional psychiatric disorders in a geriatric ward of a general psychiatric hospital using the 'Amsterdam Dementia-Screening Test'].

  1994cited by this paper
• Loss of brain 5-HT2 receptors in Alzheimer's disease. In vivo assessment with positron emission tomography and [18F]setoperone.

  1993cited by this paper
• Modulation of Central Cholinergic Activity by GABA and Serotonin: PET Studies with 11C-Benztropine in Primates

  1993cited by this paper
• Neuroreceptor changes in Alzheimer disease.

  1992cited by this paper
• Neurologic Motor Signs in Early and Late Onset Alzheimer's Disease

  1992cited by this paper
• Critical issues in defining the role of serotonin in psychiatric disorders.

  1991cited by this paper
• Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem.

  1990cited by this paper
• Aging and Alzheimer's disease. Altered cortical serotonergic binding.

  1989cited by this paper
• Serotonin receptors in the human brain--IV. Autoradiographic mapping of serotonin-2 receptors.

  1987cited by this paper
• Assessment in Geriatric Psychopharmacology

  1986cited by this paper
• Evidence for the existence of serotonin type-2 receptors on cholinergic terminals in rat cortex.

  1985cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides.

  1984cited by this paper
• Serotonin Receptor Changes in Dementia of the Alzheimer Type

  1984cited by this paper
• EFFECTS OF AGE ON DOPAMINE AND SEROTONIN RECEPTORS MEASURED BY POSITRON TOMOGRAPHY IN THE LIVING HUMAN BRAIN

  1984cited by this paper
• Development and validation of a geriatric depression screening scale: a preliminary report.

  1982cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Neurotransmitters and Immunity: Molecular Mechanisms, Biological Functions, Diseases, and Potential Therapeutic Targets

  2025cites this paper
• [18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors.

  2025cites this paper
• Targeting the serotonergic system in the treatment of neurodegenerative diseases—emerging therapies and unmet challenges

  2025cites this paper
• Role of Serotonin in the Neurobiology of Schizophrenia and Association With Negative Symptoms.

  2025cites this paper
• Multimodal brain age prediction using machine learning: combining structural MRI and 5-HT2AR PET-derived features

  2024cites this paper
• Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner.

  2024cites this paper
• Monoamine alterations in Alzheimer’s disease and their implications in comorbid neuropsychiatric symptoms

  2024cites this paper
• Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response

  2024cites this paper
• Psilocybin for the treatment of Alzheimer’s disease

  2024cites this paper
• Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms

  2024cites this paper
• Oligonol ameliorates liver function and brain function in the 5 × FAD mouse model: transcriptional and cellular analysis.

  2023cites this paper
• Putative pathological mechanisms of late-life depression and Alzheimer's Disease.

  2023cites this paper
• Radiotracers for the Central Serotoninergic System

  2022cites this paper
• Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States.

  2021cites this paper
• Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy

  2021cites this paper
• Gene Expression Profile in Different Age Groups and Its Association with Cognitive Function in Healthy Malay Adults in Malaysia

  2021cites this paper
• Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.

  2021cites this paper
• Alterations in dopamine system and in its connectivity with serotonin in a rat model of Alzheimer’s disease

  2021cites this paper
• Sex differences in neuroimaging biomarkers in healthy subjects and dementia

  2021cites this paper
• Psychiatric Disorders in Dementia

  2020cites this paper
• Imaging of the Serotonin System: Radiotracers and Applications in Memory Disorders

  2020cites this paper
• Involvement of 5-HT2 serotonin receptors in cognitive defects induced by aristolochic acid I in mice.

  2020cites this paper
• Dopamine sensing with robust carbon nanotube implanted polymer micropillar array electrodes fabricated by coupling micromolding and infiltration coating processes

  2020cites this paper
• The Potential Roles of Ghrelin in Metabolic Syndrome and Secondary Symptoms of Alzheimer’s Disease

  2020cites this paper
• Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder.

  2020cites this paper
• Serotonergic system, cognition, and BPSD in Alzheimer's disease.

  2019cites this paper
• AD molecular: Molecular imaging of Alzheimer's disease: PET imaging of neurotransmitter systems.

  2019cites this paper
• Innovative Molecular Imaging for Clinical Research, Therapeutic Stratification, and Nosography in Neuroscience

  2019cites this paper
• Key periods of cognitive decline in a nonhuman primate model of cognitive aging, the common marmoset (Callithrix jacchus).

  2019cites this paper
• The Hyperactivity–Impulsivity–Irritiability–Disinhibition–Aggression–Agitation Domain in Alzheimer’s Disease: Current Management and Future Directions

  2019cites this paper
• Protective effects of 5-HT1A receptor antagonist and 5-HT2A receptor agonist on the biochemical and histological features in a rat model of Alzheimer's disease.

  2019cites this paper
• Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint?

  2019cites this paper
• Role of Serotonin-2A Receptors in Pathophysiology and Treatment of Depression

  2018cites this paper
• PET Imaging of the 5-HT 2A Receptor System: A Tool to Study the Receptor’s In Vivo Brain Function

  2018cites this paper
• Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease.

  2017cites this paper
• Sex steroid hormone effects on cerebral serotonin-1 A receptor binding measured by positron emission tomography

  2017cites this paper
• New Trends and Current Status of Positron-Emission Tomography and Single-Photon-Emission Computerized Tomography Radioligands for Neuronal Serotonin Receptors and Serotonin Transporter.

  2017cites this paper
• Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes

  2017cites this paper
• Imaging of Neurotransmitter Systems in Dementia

  2016cites this paper
• G-protein coupled receptors as therapeutic targets for neurodegenerative and cerebrovascular diseases.

  2016cites this paper
• Amyloid imaging: Past, present and future perspectives.

  2016cites this paper
• The serotonergic system and cognitive function

  2016cites this paper
• Drug Development in Alzheimer’s Disease: The Contribution of PET and SPECT

  2016cites this paper
• Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases

  2016cites this paper
• The 5-HT2A serotonin receptor in executive function: Implications for neuropsychiatric and neurodegenerative diseases.

  2016cites this paper
• A functional 5HT2A receptor polymorphism (His452Tyr) and memory performances in Alzheimer's disease

  2015cites this paper
• The role of serotonin 5-HT2A receptors in memory and cognition

  2015influential citation
• Niveles plasmáticos de triptófano en pacientes cubanos con esquizofrenia

  2014cites this paper
• 5‐HT radioligands for human brain imaging with PET and SPECT

  2013cites this paper
• The serotonergic system in ageing and Alzheimer's disease.

  2012influential citation
• Age Effects on Serotonin Receptor 1B as Assessed by PET

  2012cites this paper
• Altered serotonergic neurotransmission as a main player in the pathophysiology of Alzheimer's disease : structural and ultrastructural studies in a triple transgenic mouse model of the disease

  2012cites this paper
• Extended characterisation of the serotonin 2A (5-HT2A) receptor-selective PET radiotracer 11C-MDL100907 in humans: Quantitative analysis, test-retest reproducibility, and vulnerability to endogenous 5-HT tone

  2012influential citation
• Depression and Alzheimer's Disease: Is Stress the Initiating Factor in a Common Neuropathological Cascade?

  2011cites this paper
• Neuroimaging of Alzheimer’s Disease, Mild Cognitive Impairment, and Other Dementias

  2011cites this paper
• Emotion and Behavior in Alzheimer's Disease and Other Dementias

  2011cites this paper
• Biomarkers in Alzheimer's disease drug development

  2011cites this paper
• Dopamine D1 receptor associations within and between dopaminergic pathways in younger and elderly adults: links to cognitive performance.

  2011cites this paper
• Plaque Deposition Dependent Decrease in 5-HT2A Serotonin Receptor in AβPPswe/PS1dE9 Amyloid Overexpressing Mice

  2010cites this paper
• Soluble βamyloid1‐42: a critical player in producing behavioural and biochemical changes evoking depressive‐related state?

  2010cites this paper
• Test-retest variability of high resolution positron emission tomography (PET) imaging of cortical serotonin (5HT2A) receptors in older, healthy adults

  2009cites this paper
• In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.

  2009cites this paper
• The Impact of Genetic Research on our Understanding of Normal Cognitive Ageing: 1995 to 2009

  2009cites this paper
• Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.

  2009influential citation
• Towards a neurocircuitry in anorexia nervosa: evidence from functional neuroimaging studies.

  2009cites this paper
• Kernel Methods for De-noising with Neuroimaging Application

  2009cites this paper
• Commentary: Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT2A levels.

  2008cites this paper
• Sex differences in the serotonin-1A receptor distribution of the human brain measured by positron emission tomography

  2008cites this paper
• Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study.

  2008cites this paper
• The ART of Loss: Aβ Imaging in the Evaluation of Alzheimer’s Disease and other Dementias

  2008cites this paper
• Colocalisation of serotonin2A receptors with the glutamate receptor subunits NR1 and GluR2 in the dentate gyrus: an ultrastructural study of a modulatory role.

  2008cites this paper
• Small molecule receptors as imaging targets.

  2008cites this paper
• Reduced 5-HT2A receptor binding in patients with mild cognitive impairment.

  2008cites this paper
• Multimodal analysis of the serotonergic neurotransmitter system

  2008cites this paper
• In Vivo Imaging of Neurotransmission and Brain Receptors in Dementia

  2008cites this paper
• Learning to avoid in older age.

  2008cites this paper
• SYNTHESIS AND IN VIVO EVALUATION OF ( 123 I)-3-I-CO

  2008cites this paper
• Learning to Avoid in Older Age

  2008cites this paper
• Abeta(1-42) injection causes memory impairment, lowered cortical and serum BDNF levels, and decreased hippocampal 5-HT(2A) levels.

  2008cites this paper
• The brain serotonin transporter binding in young adults; methodological considerations and association with Bulimia Nervosa and acquired obesity

  2008cites this paper
• A review of the literature on neuroimaging of serotoninergic function in Alzheimer’s disease and related disorders

  2007cites this paper
• Polymorphism of the 5-HT 2 A receptor gene : Association with stress-related indices in healthy middle-aged adults

  2007cites this paper
• Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease.

  2007cites this paper
• HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies.

  2007cites this paper
• Polymorphism of the 5-HT2A Receptor Gene: Association with Stress-Related Indices in Healthy Middle-Aged Adults

  2007cites this paper
• Selective immunolesion of cholinergic neurons leads to long-term changes in 5-HT2A receptor levels in hippocampus and frontal cortex.

  2007cites this paper
• Radiopharmaceuticals: Recent Developments and Trends

  2006cites this paper
• Kognitive Störungen: Koma, Delir, Demenz

  2006cites this paper
• La Lunga Attesa: Towards a Molecular Approach to Neuroimaging and Therapeutics in Alzheimer's Disease

  2006cites this paper
• Longitudinal change in memory performance associated with HTR2A polymorphism.

  2006cites this paper
• Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: Part 1--pseudoequilibrium interval and quantification methods.

  2006cites this paper
• Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype.

  2005cites this paper
• Age-dependent effects of the 5-hydroxytryptamine-2a-receptor polymorphism (His452Tyr) on human memory

  2005cites this paper
• Trends in brain oxygenation during mental and physical exercise measured using near-infrared spectroscopy (NIRS): potential for early detection of Alzheimer's disease

  2005cites this paper
• Neurotoxic Oxidative Metabolite of Serotonin

  2005cites this paper
• Serotonin, Kognition, Demenz

  2005cites this paper
• Neuroprotection and Neurodegenerative Diseases: From Biology to Clinical Practice

  2005cites this paper
• Genetic variants implicated in personality: A review of the more promising candidates

  2004cites this paper
• Neuroreceptor Imaging of Stress and Mood Disorders

  2004cites this paper
• Aus der Klinik und Poliklinik für Psychiatrie und Psychotherapie der Ludwig-Maximilians-Universität München

  2004cites this paper